Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting and evaluating clinical data on Rezum, a water vapor therapy used to treat benign prostate obstruction BPO and lower urinary tract symptoms LUTS in men. This large, prospective, multi-center study aims to assess the treatments effectiveness, durability, and safety in 1000 real-life patients with a follow-up period of 5 years. The study particularly focuses on patient-reported outcomes and clinical outcomes to better understand the role of Rezum in managing BPO-related symptoms. Rezum treatment involves delivering steam injections transurethrally into the enlarged prostate tissue. The hot steam causes prostate tissue to shrink over several months, improving symptoms while preserving sexual function. The procedure is minimally invasive, quick, and can be done under local anesthesia. Patients treated with Rezum will be enrolled in a German-language web-based database to record various outcome measures, including sexual function, safety, recovery, patient satisfaction, and quality of life. Participants will complete several validated questionnaires and clinical assessments at multiple time points from baseline up to 5 years after treatment. These include symptom scores, urinary flow measurements, sexual health questionnaires, pain scales, and imaging results. Data on side effects, medication use, reoperations, and prostate size changes will also be collected. If patients have a smartphone, they may use a home uroflowmetry app to monitor urine flow conveniently. The study will monitor safety events and treatment durability throughout the follow-up period.